GAM Holding’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

GAM Holding’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-62,200	Closed	-$2.99M	–	379
2020 Q1	$2.99M	Buy	62,200 +26,700	+75%	+$1.24M	0.2%	138
2019 Q4	$1.67M	Buy	+35,500	New	+$1.57M	0.08%	252

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

GAM Holding's RARX Position: Q2 2020 in Review

GAM Holding sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 62,200 shares — an estimated $2.99M sold.

GAM Holding first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $2.99M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

GAM Holding reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
GAM Holding sold 62,200 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $2.99M.
GAM Holding first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
GAM Holding's Ra Pharmaceuticals, Inc. Common Stock position peaked at $2.99M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on GAM Holding's 13F filing for Q2 2020, filed 10 Aug 2020.